Clinical Trial Update: Efficacy and Safety of Everolimus With Enteric-Coated Mycophenolate Sodium (EC-MPS) in a Cyclosporine Microemulsion-free Regimen Compared to Standard Therapy in de Novo Renal Transplant Patients [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating the efficacy and safety of everolimus with enteric-coated mycophenolate sodium in a cyclosporine-free regimen versus standard therapy i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Transplantation

Drugs mentioned

• Everolimus (everolimus)
• MYFORTIC (MYCOPHENOLIC ACID)

Snippet

Sponsor: Novartis | Conditions: Renal Transplantation | Phase 4 | Status: COMPLETED | Results posted: 2011-05-24